ALEXANDRIA, Va., Sept. 10 -- United States Patent no. 12,410,156, issued on Sept. 9, was assigned to INSILICO MEDICINE IP Ltd. (Hong Kong, Hong Kong).
"Kinase inhibitors" was invented by Aleksandr Aliper (Moscow), Vladimir Aladinskiy (Moscow) and Aleksandrs Zavoronkovs (Pak Shek Kok, Hong Kong).
According to the abstract* released by the U.S. Patent & Trademark Office: "A TNIK and/or MAP4K4 kinase inhibitor can include: Formula A, derivative, prodrug, salt, stereoisomer, tautomer polymorph, or solvate thereof, or having chirality at any chiral center, wherein: ring 1 is an aromatic ring with or without hetero atoms; ring 2 is a hetero aromatic ring; ring 3 includes at least one hetero aromatic ring and optionally at least one cycloaliphat...